Market Cap 12.90B
Revenue (ttm) 739.02M
Net Income (ttm) -436.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -59.05%
Debt to Equity Ratio -3.14
Volume 1,042,400
Avg Vol 2,690,880
Day's Range N/A - N/A
Shares Out 126.04M
Stochastic %K 77%
Beta 1.58
Analysts Strong Sell
Price Target $116.43

Company Profile

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company provides precision oncology testing services comprising Guardant360, a panel of genetic tests; Guardant360 LDT that measures 730+ genes and supports all guideline-recommended biomarkers; Guardant360 CDx Test, a liquid biopsy test; Guardant360 Response Test, a blood-only liquid biopsy; Guardant360 TissueNext Test, a tissue-based test with AI-pow...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 855 698 8887
Fax: 888 974 4258
Address:
3100 Hanover Street, Palo Alto, United States
Gator5326
Gator5326 Dec. 26 at 10:06 PM
$GH 1 week until Quest revenues start flowing! 😎
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 2:20 PM
Actionable Trade Alert for $GH: Market Context: $GH is currently trading at $102.38, showing a bearish sentiment with an RSI of 37.11, indicating potential oversold conditions. The price is above the 30-day moving average (MA30) of 102.07 but significantly above the 50-day moving average (MA50) of 93.71, suggesting a possible short-term rebound. Directional Bias: The RSI indicates a potential reversal, while the price action is near the 60-day low of 60.45. This creates a favorable setup for a bullish trade as it approaches a support level. Trade Plan: - Suggested Entry: $102.50 - Stop Loss: $98.00 (4.9% risk) - Take Profit Targets: 1. $108.00 (5.5% gain) 2. $112.00 (9.3% gain) 3. $120.00 (17.2% gain) With this plan, a successful trade could yield an ROI of over 17% on the third target, capitalizing on the potential price rebound. https://privateprofiteers.com
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 24 at 5:48 PM
$GH RSI: 37.48, MACD: 1.5038 Vol: 3.17, MA20: 102.93, MA50: 93.71 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
JFDI
JFDI Dec. 22 at 7:16 PM
$GH Ripe
0 · Reply
123rs123
123rs123 Dec. 22 at 2:06 PM
$GH based on q3 results, i think this will go to 200 by end of 2026
1 · Reply
JarvisFlow
JarvisFlow Dec. 22 at 12:50 PM
Canaccord Genuity has updated their rating for Guardant Health ( $GH ) to Buy with a price target of 125.
0 · Reply
Gator5326
Gator5326 Dec. 20 at 12:19 AM
$GH more bullish then ever! $GH is just getting started. A true beast in the making!
0 · Reply
ils85
ils85 Dec. 19 at 9:14 PM
0 · Reply
ils85
ils85 Dec. 19 at 9:14 PM
$GH still bullish but not at this price anymore - out of 80% of position here core still on from 48$
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 4:15 PM
$GH Trade Alert: Market Context: Currently, $GH is trading at $97.1, with an RSI of 29.42 indicating oversold conditions. The stock is below both the 30-day moving average (MA30) of 101.49 and the 50-day moving average (MA50) of 90.66, suggesting a bearish trend. However, the RSI indicates potential for a reversal. Directional Bias: The oversold RSI combined with the proximity to the 60-day low of 58.74 suggests a possible bounce back. If the stock can break above the MA30, it may signal a bullish reversal. Trade Plan: - Suggested Entry: $97.1 - Stop Loss: $90 (below MA50) - Take Profit Targets: - Target 1: $105 (7.4% ROI) - Target 2: $110 (13.3% ROI) - Target 3: $114 (17.5% ROI) This trade plan allows for a significant upside with a clear stop loss to manage risk. Monitor the price action closely for confirmation of the reversal. https://privateprofiteers.com
0 · Reply
Latest News on GH
5 Top Stocks For AI Fatigue

Nov 28, 2025, 11:47 AM EST - 4 weeks ago

5 Top Stocks For AI Fatigue

AMBP GSL OHI PARR


6 Healthcare Stocks With Strong Upward Momentum

Nov 18, 2025, 12:59 PM EST - 5 weeks ago

6 Healthcare Stocks With Strong Upward Momentum

ABVX CAH ELAN MEDP WGS


Guardant Health: Business Continues To Gather Pace

Oct 30, 2025, 9:03 PM EDT - 2 months ago

Guardant Health: Business Continues To Gather Pace


Guardant Health, Inc. (GH) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 1:46 AM EDT - 2 months ago

Guardant Health, Inc. (GH) Q3 2025 Earnings Call Transcript


Guardant Health, Inc. (GH) Analyst/Investor Day Transcript

Sep 24, 2025, 7:17 PM EDT - 3 months ago

Guardant Health, Inc. (GH) Analyst/Investor Day Transcript


Alex M. Azar II Joins Guardant Health Board of Directors

Sep 15, 2025, 4:07 PM EDT - 3 months ago

Alex M. Azar II Joins Guardant Health Board of Directors


Guardant Health to Host Investor Day on September 24, 2025

Aug 28, 2025, 4:05 PM EDT - 4 months ago

Guardant Health to Host Investor Day on September 24, 2025


Guardant Health, Inc. (GH) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 11:13 AM EDT - 5 months ago

Guardant Health, Inc. (GH) Q2 2025 Earnings Call Transcript


Gator5326
Gator5326 Dec. 26 at 10:06 PM
$GH 1 week until Quest revenues start flowing! 😎
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 2:20 PM
Actionable Trade Alert for $GH: Market Context: $GH is currently trading at $102.38, showing a bearish sentiment with an RSI of 37.11, indicating potential oversold conditions. The price is above the 30-day moving average (MA30) of 102.07 but significantly above the 50-day moving average (MA50) of 93.71, suggesting a possible short-term rebound. Directional Bias: The RSI indicates a potential reversal, while the price action is near the 60-day low of 60.45. This creates a favorable setup for a bullish trade as it approaches a support level. Trade Plan: - Suggested Entry: $102.50 - Stop Loss: $98.00 (4.9% risk) - Take Profit Targets: 1. $108.00 (5.5% gain) 2. $112.00 (9.3% gain) 3. $120.00 (17.2% gain) With this plan, a successful trade could yield an ROI of over 17% on the third target, capitalizing on the potential price rebound. https://privateprofiteers.com
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 24 at 5:48 PM
$GH RSI: 37.48, MACD: 1.5038 Vol: 3.17, MA20: 102.93, MA50: 93.71 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
JFDI
JFDI Dec. 22 at 7:16 PM
$GH Ripe
0 · Reply
123rs123
123rs123 Dec. 22 at 2:06 PM
$GH based on q3 results, i think this will go to 200 by end of 2026
1 · Reply
JarvisFlow
JarvisFlow Dec. 22 at 12:50 PM
Canaccord Genuity has updated their rating for Guardant Health ( $GH ) to Buy with a price target of 125.
0 · Reply
Gator5326
Gator5326 Dec. 20 at 12:19 AM
$GH more bullish then ever! $GH is just getting started. A true beast in the making!
0 · Reply
ils85
ils85 Dec. 19 at 9:14 PM
0 · Reply
ils85
ils85 Dec. 19 at 9:14 PM
$GH still bullish but not at this price anymore - out of 80% of position here core still on from 48$
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 4:15 PM
$GH Trade Alert: Market Context: Currently, $GH is trading at $97.1, with an RSI of 29.42 indicating oversold conditions. The stock is below both the 30-day moving average (MA30) of 101.49 and the 50-day moving average (MA50) of 90.66, suggesting a bearish trend. However, the RSI indicates potential for a reversal. Directional Bias: The oversold RSI combined with the proximity to the 60-day low of 58.74 suggests a possible bounce back. If the stock can break above the MA30, it may signal a bullish reversal. Trade Plan: - Suggested Entry: $97.1 - Stop Loss: $90 (below MA50) - Take Profit Targets: - Target 1: $105 (7.4% ROI) - Target 2: $110 (13.3% ROI) - Target 3: $114 (17.5% ROI) This trade plan allows for a significant upside with a clear stop loss to manage risk. Monitor the price action closely for confirmation of the reversal. https://privateprofiteers.com
0 · Reply
Gator5326
Gator5326 Dec. 18 at 1:35 PM
$GH All these upgrades and backwards we go?
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 3:05 PM
Mizuho updates rating for Guardant Health ( $GH ) to Outperform, target set at 100 → 120.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 3:02 AM
$GH Trade Alert: Current market context indicates a bearish trend with the last close at $100.00 and an RSI of 33.22, suggesting oversold conditions. The MA30 at $101.45 is above the current price, indicating resistance, while the MA50 at $89.35 provides potential support. The 60D high at $112.43 and low at $55.38 shows a wide trading range, providing opportunities for price movement. Directional Bias: Bearish to neutral, with a potential reversal as the RSI is approaching oversold levels. Trade Plan: - Suggested Entry: $100.00 - Stop Loss: $95.00 (5% risk) - Take Profit Targets: 1. TP1: $105.00 (5% gain) 2. TP2: $110.00 (10% gain) 3. TP3: $117.00 (17% gain) This plan allows for a structured approach to capitalize on potential upward movement while managing risk effectively. For further insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
IN0V8
IN0V8 Dec. 16 at 8:30 PM
$GH Buy Jefferies raises target price to $130 from $115
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 9:00 PM
Barclays updates rating for Guardant Health ( $GH ) to Overweight, target set at 85 → 120.
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 8:47 PM
Leerink Partners has updated their rating for Guardant Health ( $GH ) to Outperform with a price target of 155.
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 7:08 PM
JP Morgan has updated their rating for Guardant Health ( $GH ) to Overweight with a price target of 120.
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 6:19 PM
Wells Fargo has adjusted their stance on Guardant Health ( $GH ), setting the rating to Overweight with a target price of 93 → 120.
0 · Reply
Dr_Stoxx
Dr_Stoxx Dec. 15 at 4:20 PM
$GH another healthcare play that can be bought here
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 6:35 AM
$GH: Current market context shows a close at $102.07 with an RSI of 44.64, indicating a neutral sentiment. The price is above the 30-day moving average (MA30) of $101.09, suggesting potential bullish momentum. However, the RSI indicates there is room for upward movement before reaching overbought conditions. Directional bias leans bullish due to the price being above MA30 and the proximity to the 60-day high of $112.43. The 60-day low of $55.38 provides a solid support level. Suggested trade plan: - Entry: $102.50 (slightly above last close) - Stop Loss: $98.00 (4.5% below entry) - Take Profit Targets: - TP1: $108.00 (5.5% gain) - TP2: $112.00 (9.3% gain) - TP3: $119.00 (16.1% gain) This plan offers a potential ROI of over 17% on TP3 while managing risk effectively. Monitor price action closely. https://privateprofiteers.com
0 · Reply
anachartanalyst
anachartanalyst Dec. 12 at 12:01 PM
$GH https://anachart.com/wp-content/uploads/ana_temp/1765540879_soc-img.jpg
0 · Reply
JarvisFlow
JarvisFlow Dec. 12 at 11:10 AM
BTIG updates rating for Guardant Health ( $GH ) to Buy, target set at 100 → 140.
1 · Reply